A major international study has assessed key bacterial targets that could form the basis of a new maternal vaccine to protect newborns from life-threatening infections. The University of Strathclyde contributed analytical expertise to the global project, as part of a long-standing collaboration with leading clinical scientists from the U.K. and Malawi.
Source link
About the Author
